Related Experiment Video
Updated: May 15, 2026
08:33
A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
Published on: December 15, 2014
The neutrophil in chronic obstructive pulmonary disease
Kim Hoenderdos1, Alison Condliffe
1University of Cambridge, Cambridge, United Kingdom.
American Journal of Respiratory Cell and Molecular Biology
|January 19, 2013
Summary
Chronic obstructive pulmonary disease (COPD) involves persistent inflammation and neutrophil dysfunction. Hypoxia exacerbates this, impairing bacterial killing and increasing tissue-damaging protease release in COPD patients.
Area of Science:
- Pulmonary Medicine
- Immunology
- Cell Biology
Background:
- Chronic obstructive pulmonary disease (COPD) is a major global health issue with limited treatment options.
- COPD is characterized by persistent local and systemic inflammation, particularly neutrophilic inflammation.
- Recurrent infections exacerbate COPD progression despite the presence of innate immune cells.
Purpose of the Study:
- To investigate the role of neutrophil elastase and other neutrophil-derived proteases in COPD pathogenesis.
- To explore the impact of hypoxia on neutrophil function in the context of COPD.
- To understand how hypoxia-induced neutrophil dysfunction contributes to COPD progression.
Main Methods:
- Review of existing evidence including cell culture, murine models, and human genetic studies (alpha-1-antitrypsin deficiency).
- Analysis of the known roles of cytokines in neutrophil modulation.
- Examination of recent findings on hypoxia's effects on neutrophil behavior.
Main Results:
- Neutrophil elastase and related proteases are implicated as key mediators of tissue damage and lung function decline in COPD.
- Hypoxia impairs neutrophil ability to kill bacteria and enhances protease release.
- Hypoxia also delays neutrophil apoptosis, prolonging their destructive potential.
Conclusions:
- Neutrophil-derived proteases are central to COPD-related tissue damage and lung function loss.
- Hypoxia significantly alters neutrophil function, promoting a destructive phenotype.
- The detrimental effects of hypoxia on neutrophils are likely a critical factor in the COPD microenvironment.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.